|
|
|
|||||||
|
|||||||||
J. Biol. Chem., Vol. 279, Issue 10, 9115-9124, March 5, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Slit Protein-mediated Inhibition of CXCR4-induced Chemotactic and Chemoinvasive Signaling Pathways in Breast Cancer Cells*
From the
Division of Experimental Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02115 and the Department of Anatomy and Neurobiology, Washington University School of Medicine, St. Louis, Missouri 63110
Slit, which mediates its function by binding to the Roundabout (Robo) receptor, has been shown to regulate neuronal and CXCR4-mediated leukocyte migration. Slit-2 was shown to be frequently inactivated in lung and breast cancers because of hypermethylation of its promoter region. Furthermore, the CXCR4/CXCL12 axis has been reported recently to be actively involved in breast cancer metastasis to target organs such as lymph nodes, lung, and bone. In this study, we sought to characterize the effect of Slit (=Slit-2) on the CXCL12/CXCR4-mediated metastatic properties of breast cancer cells. We demonstrate here that breast cancer cells and tissues derived from breast cancer patients express Robo 1 and 2 receptors. We also show that Slit treatment inhibits CXCL12/CXCR4-induced breast cancer cell chemotaxis, chemoinvasion, and adhesion, the fundamental components that promote metastasis. Slit had no significant effect on the CXCL12-induced internalization process of CXCR4. In addition, characterization of signaling events revealed that Slit inhibits CXCL12-induced tyrosine phosphorylation of focal adhesion components such as RAFTK/Pyk2 at residues 580 and 881, focal adhesion kinase at residue 576, and paxillin. We found that Slit also inhibits CXCL12-induced phosphatidylinositol 3-kinase, p44/42 MAP kinase, and metalloproteinase 2 and 9 activities. However, it showed no effect on JNK and p38 MAP kinase activities. To our knowledge, this is the first report to analyze in detail the effect of Slit on breast cancer cell motility as well as its effect on the critical components of the cancer cell chemotactic machinery. Studies of the Slit-Robo complex may foster new anti-chemotactic approaches to block cancer cell metastasis.
Received for publication, July 24, 2003 , and in revised form, November 18, 2003.
* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Harvard Institutes of Medicine, BIDMC, 4 Blackfan Circle, Room 343, Boston, MA 02115. Tel.: 617-667-0060; Fax: 617-975-5240; E-mail: rganju{at}bidmc.harvard.edu.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. C. Stella, L. Trusolino, and P. M. Comoglio The Slit/Robo System Suppresses Hepatocyte Growth Factor-dependent Invasion and Morphogenesis Mol. Biol. Cell, January 1, 2009; 20(2): 642 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Marlow, P. Strickland, J. S. Lee, X. Wu, M. PeBenito, M. Binnewies, E. K. Le, A. Moran, H. Macias, R. D. Cardiff, et al. SLITs Suppress Tumor Growth In vivo by Silencing Sdf1/Cxcr4 within Breast Epithelium Cancer Res., October 1, 2008; 68(19): 7819 - 7827. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Dickinson, M. Myers, and W. C. Duncan Novel Regulated Expression of the SLIT/ROBO Pathway in the Ovary: Possible Role during Luteolysis in Women Endocrinology, October 1, 2008; 149(10): 5024 - 5034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Prasad, V. Paruchuri, A. Preet, F. Latif, and R. K. Ganju Slit-2 Induces a Tumor-suppressive Effect by Regulating {beta}-Catenin in Breast Cancer Cells J. Biol. Chem., September 26, 2008; 283(39): 26624 - 26633. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Morlot, N. M. Thielens, R. B. G. Ravelli, W. Hemrika, R. A. Romijn, P. Gros, S. Cusack, and A. A. McCarthy Structural insights into the Slit-Robo complex PNAS, September 18, 2007; 104(38): 14923 - 14928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Prasad, Z. Qamri, J. Wu, and R. K. Ganju Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells J. Leukoc. Biol., September 1, 2007; 82(3): 465 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. F. Rosenberg Putting the brakes on leukocyte chemotaxis: an interview with Dr. Ramesh K. Ganju J. Leukoc. Biol., September 1, 2007; 82(3): 477 - 478. [Full Text] [PDF]
|
|
|
|
|
|
N. P. Ly, K. Komatsuzaki, I. P. Fraser, A. A. Tseng, P. Prodhan, K. J. Moore, and T. B. Kinane Netrin-1 inhibits leukocyte migration in vitro and in vivo PNAS, October 11, 2005; 102(41): 14729 - 14734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kishimoto, Z. Wang, P. Bhat-Nakshatri, D. Chang, R. Clarke, and H. Nakshatri The p160 family coactivators regulate breast cancer cell proliferation and invasion through autocrine/paracrine activity of SDF-1{alpha}/CXCL12 Carcinogenesis, October 1, 2005; 26(10): 1706 - 1715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Park, D. Crouse, M. Lee, S. K. Karnik, L. K. Sorensen, K. J. Murphy, C. J. Kuo, and D. Y. Li The axonal attractant Netrin-1 is an angiogenic factor PNAS, November 16, 2004; 101(46): 16210 - 16215. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |